Japan News
-
Eisai launches Parkinson's drug in Japan
Japan | News | 0 Comment | 25 Nov, 2019
Tokyo headquartered Eisai Co., Ltd. announced that it has launched the Equfina® 50mg TABLETS (safinamide mesilate, “Equfina”) for the indication of improvement of weari...Read more
-
Astellas and Welldoc collaborate for digital therapeutics
Japan | News | 0 Comment | 22 Nov, 2019
Japan headquartered Astellas Pharma Inc. and US based Welldoc, Inc. have entered into a collaboration and license agreement directed toward the development and commercialization of digital ...Read more
-
Japan grants ODD to Merck's investigational therapy Tepotinib
Japan | News | 0 Comment | 21 Nov, 2019
Merck, a leading science and technology company, has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) for its investigatio...Read more
-
Toray signs pact with JICA to support infection control capacity
Japan | News | 0 Comment | 20 Nov, 2019
Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA) to undertake a project to promote deployment and utilization of Japa...Read more
-
Novartis to buy Aspen’s Japanese operations
Japan | News | 0 Comment | 18 Nov, 2019
Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen...Read more
-
Japan | News | 0 Comment | 18 Nov, 2019
Indian pharma major Lupin Limited (including its subsidiaries, together referred to as ‘Lupin’) announced that it has entered into a definitive agreement for the sale...Read more
-
Clinical Trial of Boron Neutron Capture Therapy commences in Japan
Japan | News | 0 Comment | 18 Nov, 2019
Cancer Intelligence Care Systems, Inc. (CICS) and STELLA PHARMA CORPORATION will commence a Phase I clinical trial of Boron Neutron Capture Therapy (BNCT) for malignant melanoma and angiosa...Read more
-
Takeda announces 12 new molecular entities
Japan | News | 0 Comment | 15 Nov, 2019
Japan headquartered Takeda Pharmaceutical Company Limited recentky hosted an R&D meeting in New York City to outline how its science-first, patient-centric strategy, diverse portfo...Read more
-
NEC, VAXIMM to advance personalized neoantigen cancer vaccines
Japan | News | 0 Comment | 15 Nov, 2019
Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, announced that the com...Read more
-
Yokogawa acquires nanopipette technology for life science applications
Japan | News | 0 Comment | 14 Nov, 2019
Japan headquartered Yokogawa Electric Corporation announces that it has acquired a nanopipette technology that was developed by BioStinger, Inc., a spin-off from the University of Californi...Read more
-
Novo Nordisk obtains worldwide licence to potential NASH candidate
Japan | News | 0 Comment | 08 Nov, 2019
Novo Nordisk A/S and Japanese chemical company UBE Industries Ltd. recently announced that Novo Nordisk has obtained an exclusive worldwide licence to UBE’s preclinical asset UD-014, ...Read more
-
Takeda, Anderson Cancer Center accelerate cell therapy
Japan | News | 0 Comment | 12 Nov, 2019
University of Texas MD Anderson Cancer Center (The University of Texas MD Anderson Cancer Center) and Takeda Pharmaceutical Company Limited (Takeda Pharmaceutical has announc...Read more
-
Kayentis opens Japanese subsidiary
Japan | News | 0 Comment | 11 Nov, 2019
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) solutions for clinical trials, has announced the opening of a subsidiary in Japan, the world’s third large...Read more
-
Fujitsu improves efficiency in Cancer Genomic Medicine in joint AI research
Japan | News | 0 Comment | 08 Nov, 2019
Fujitsu, on 7 Nov 2019, announced the results of a joint research project it has been conducting with the Institute of Medical Science at the University of Tokyo since April 2018. As part o...Read more
-
Takeda’s Dengue vaccine candidate reveals protection in children
Japan | News | 0 Comment | 08 Nov, 2019
Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of the ongoing pivotal Phase 3 Tetravalent Immunization against Den...Read more
-
Hitachi collaborates with CLB to fight cancer using AI
Japan | News | 0 Comment | 07 Nov, 2019
Tokyo headquartered Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, have announced that they have entered into an agreement to joint...Read more
-
Olympus unveils corporate strategy
Japan | News | 0 Comment | 07 Nov, 2019
Olympus Corporation has announced its Corporate Strategy in central Tokyo. The announcement follows the company's earlier announcement in January this year, when significant changes in...Read more
-
Takeda divests select products to STADA for $660M
Japan | News | 0 Comment | 06 Nov, 2019
Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG, an international pha...Read more
